Health
Monoclonal Antibody Combo Treatment Reduces Viral Load in COVID – Medscape
Bamlanivimab and etesevimab together were associated with a statistically significant reduction in SARS-CoV-2. Bamlanivimab alone, however, showed no significant…
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
A combination treatment of neutralizing monoclonal antibodies bamlanivimab and etesevimab was associated with a statistically significant reduction in SARS-CoV-2 at day 11 compared with placebo among nonhospitalized patients who had mild-to-moderate COVID-19, new data indicate.
However, bamlanivimab alone in three different single-infusion doses showed no significant reduction in viral load compared…
-
Noosa News19 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News20 hours agoMotorcyclist dies in crash with truck
-
Noosa News20 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
Noosa News18 hours agoAustralia Post reintroduces weekend deliveries for Christmas parcel rush